Trials / Completed
CompletedNCT02547454
An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
Investigating the Effectiveness of Renal Anaemia Treatment in Pre-Dialysis Patients With Mircera in Daily Clinical Practice - MIRVITA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 393 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This observational trial will examine the efficacy and safety of Mircera for renal anemia in participants with stage III-IV CKD in daily clinical practice. Mircera will be prescribed by treating physician and followed for approximately 36 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methoxy polyethylene glycol-epoetin beta |
Timeline
- Start date
- 2008-12-31
- Primary completion
- 2014-11-30
- Completion
- 2014-11-30
- First posted
- 2015-09-11
- Last updated
- 2017-06-07
- Results posted
- 2015-11-23
Locations
12 sites across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT02547454. Inclusion in this directory is not an endorsement.